Long-term Prognosis of Acute Kidney Injury in Cardiac Surgery
Long-term Prognosis of Acute Kidney Injury in Cardiac Surgery
批准号:
7666649
负责人:
Steven G Coca
金额:
$18.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2013-05-31
关键词:
AcuteAcute Renal Failure with Renal Papillary NecrosisAdultAffectAreaBackBiological MarkersCardiac Surgery proceduresCardiovascular systemCaringCessation of lifeChronicChronic Kidney FailureClinicalCocaCoronary Artery BypassCreatinineDetectionDevelopmentDialysis procedureDiseaseEnd stage renal failureExcretory functionFailureFunctional disorderFutureGlomerular Filtration RateGoalsGrantHealth ExpendituresHealth TechnologyHealthcare SystemsHeart DiseasesHigh PrevalenceHospitalizationHospitalsHypertensionIncidenceInflammatoryInterleukin-18K-Series Research Career ProgramsKidneyLeadLengthModelingMorbidity - disease rateMyocardial InfarctionOperative Surgical ProceduresOutcomePathway interactionsPatient CarePatientsPhasePhysiciansPopulationPrevalenceProteinsProteinuriaResearch PersonnelResidual stateRiskRisk AssessmentRisk FactorsSample SizeSerumSeveritiesSignal PathwayStratificationStructureSurvivorsTimeTroponinUnited Statescardiovascular disorder riskcohortdesignfallsfollow-uphazardimprovedmortalitynoveloutcome forecastpreventprognosticprogramsprospectivepublic health relevanceurinaryvigilance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
It is well known that acute kidney injury (AKI) has a marked impact on clinical outcomes, including short-term mortality. Futhermore, the incidence of AKI has increased over the past several years. At the same time, the prevalence of chronic kidney disease is high and results in a major burden for patients and for the health care system in the United States. It is unclear if AKI is a completely reversible disease, or whether it leads to permanent kidney damage and thus CKD and death.
This proposal will utilize a prospective cohort design that will add a long-term follow-up component to an ongoing multi-center 5-day study of urinary biomarkers for the detection of AKI after cardiac surgery. We will longitudinally study the patients with AKI as defined by at least a 25% increase in peri-operative serum creatinine and an equal number of patients without AKI that survive cardiac surgery at three academic centers. We will determine if AKI results in an increase in the decline in glomerular filtration rate and in increase in the protein excretion rate over time. We will compare the incidence of doubling of serum creatinine, dialysis or death in patients with and without AKI. In addition, we will examine if newly discovered biomarkers of acute kidney injury (urinary IL-18 and NGAL) are associated with CKD and death. As troponin has shown tremendous value in the setting of myocardial infarction, our hope is that these urinary biomarkers will possess long-term prognostic value for patients with AKI.
Currently, AKI is viewed by most physicians as a reversible phenomenon that has little consequence after the acute phase. If, however, AKI is truly associated with long-term morbidity and mortality, then post-AKI care of these patients should involve closer vigilance and more aggressive treatments in order to improve long-term outcomes. My hope is to obtain R01 grants in the future with the goal of improving risk- stratification of AKI and I also hope to participate in multi-center trials of therapies for AKI and its associated complications.
PUBLIC HEALTH RELEVANCE: The relationship between acute kidney injury and long-term outcomes remains unclear. These studies will attempt to determine the association between both traditional kidney exposure variables (e.g., acute change in serum creatinine) and novel kidney exposure variables (e.g., urinary biomarkers) and long-term kidney and mortality outcomes in a cohort of cardiac surgery patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leveraging Clinical Trials of Diabetic Kidney Disease to Advance Biomarkers
-
批准号:9330841
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Steven G Coca
-
依托单位:
Leveraging Clinical Trials of Diabetic Kidney Disease to Advance Biomarkers
-
批准号:9143761
-
项目类别:
-
资助金额:$44.65万
-
财政年份:2015
-
负责人:Steven G Coca
-
依托单位:
Novel serum and urinary biomarkers of diabetic kidney disease
-
批准号:8339706
-
项目类别:
-
资助金额:$65.78万
-
财政年份:2012
-
负责人:Steven G Coca
-
依托单位:
Novel serum and urinary biomarkers of diabetic kidney disease
-
批准号:8540427
-
项目类别:
-
资助金额:$63.15万
-
财政年份:2012
-
负责人:Steven G Coca
-
依托单位:
Novel serum and urinary biomarkers of diabetic kidney disease
-
批准号:8701290
-
项目类别:
-
资助金额:$61.78万
-
财政年份:2012
-
负责人:Steven G Coca
-
依托单位:
Long-term Prognosis of Acute Kidney Injury in Cardiac Surgery
-
批准号:7531110
-
项目类别:
-
资助金额:$18.52万
-
财政年份:2008
-
负责人:Steven G Coca
-
依托单位:
Long-term Prognosis of Acute Kidney Injury in Cardiac Surgery
-
批准号:7862602
-
项目类别:
-
资助金额:$19.34万
-
财政年份:2008
-
负责人:Steven G Coca
-
依托单位:
Long-term Prognosis of Acute Kidney Injury in Cardiac Surgery
-
批准号:8119718
-
项目类别:
-
资助金额:$19.53万
-
财政年份:2008
-
负责人:Steven G Coca
-
依托单位:
Long-term Prognosis of Acute Kidney Injury in Cardiac Surgery
-
批准号:8277974
-
项目类别:
-
资助金额:$19.42万
-
财政年份:2008
-
负责人:Steven G Coca
-
依托单位:
Urinary Biomarkers for Acute Kidney Injury in Critical Illness
-
批准号:7275018
-
项目类别:
-
资助金额:$6.68万
-
财政年份:2007
-
负责人:Steven G Coca
-
依托单位: